tiprankstipranks
Trending News
More News >
Xilio Therapeutics (XLO)
NASDAQ:XLO
US Market

Xilio Therapeutics (XLO) Revenue

Compare
186 Followers

Xilio Therapeutics Revenue

Xilio Therapeutics had a revenue of 2.93M in the quarter ending Mar 31, 2025, with 69.95%. This bring the company's revenue in the last twelve months to 9.27M, Decreased 46.19%. In the fiscal year ending Dec 31, 2024, Xilio Therapeutics had annual revenue of 6.34M with Infinity% growth.
Revenue (ttm)
9.27M
Revenue Growth
P/S Ratio
5.70
Revenue/Employee
$99,125
Employees
64
Market Cap
$36.14M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
6.34M+∞%
Dec 31, 2023
0.00
Dec 31, 2022
0.00
Dec 31, 2021
0.00
Dec 31, 2020
0.00
Dec 31, 2019
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis